Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
25.40
+0.22 (0.87%)
At close: Jan 23, 2026
Zhejiang Orient Gene Biotech Company Description
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide.
Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection.
The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex.
Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
Zhejiang Orient Gene Biotech Co., Ltd
| Country | China |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,276 |
| CEO | Xiaoliang Fang |
Contact Details
Address: No. 3787, East Yangguang Avenue Huzhou, 313300 China | |
| Phone | 86 57 2530 3755 |
| Website | orientgene.com |
Stock Details
| Ticker Symbol | 688298 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003RM8 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Xiaoliang Fang | GM and Director |
| Jinhong Yu | Deputy GM and Financial Manager |
| Pang Qi | Deputy General Manager |
| Jinfeng Tan | Deputy General Manager |
| Chunmei Zhong | Deputy General Manager |
| Faying Xu | Deputy General Manager |
| Yuanyuan Li | Accounting Supervisor |
| Ye Ping Zhang | Deputy GM and Secretary |
| Yun Ou Yang | Deputy General Manager |